CLINICAL_TRIALS
trial_result
· 2021-11-11
Clinical Trial Update: Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp [NA]
Summary
Feasibility study results for a Zone-MPC controller with HMS and Technosphere Insulin inhalation system in Type 1 Diabetes Mellitus have been posted following c…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sansum Diabetes Research Institute | Conditions: Type 1 Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2021-11-11